{"schema_version":"secwatch.filing_event.v1","accession":"0001326110-23-000112","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.580483+00:00","generated_at":"2026-06-11T00:23:55.543544+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ImmunityBio subsidiary to enforce settlement as Sorrento fails to pay judgments","bullets":["Sorrento failed to pay judgments held by NantCell and NANTibody by August 31, 2023 deadline.","NantCell and NANTibody to deliver certification of non-payment by September 6, triggering settlement terms.","Upon certification, mutual release of claims, release of judgments, and Sorrento relinquishes NANTibody interests.","Sorrento forfeits rights to payments from antibody license including royalties from PD-L1 t-haNK NK cell therapy."],"urls":{"canonical":"https://secwatch.observer/filing/0001326110-23-000112","json":"https://secwatch.observer/filing/0001326110-23-000112.json","markdown":"https://secwatch.observer/filing/0001326110-23-000112.md","text":"https://secwatch.observer/filing/0001326110-23-000112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000112/0001326110-23-000112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000112/ibrx-20230831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:23:55.543544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}